DE602006009296D1 - Oligopeptide und ihre verwendung - Google Patents

Oligopeptide und ihre verwendung

Info

Publication number
DE602006009296D1
DE602006009296D1 DE602006009296T DE602006009296T DE602006009296D1 DE 602006009296 D1 DE602006009296 D1 DE 602006009296D1 DE 602006009296 T DE602006009296 T DE 602006009296T DE 602006009296 T DE602006009296 T DE 602006009296T DE 602006009296 D1 DE602006009296 D1 DE 602006009296D1
Authority
DE
Germany
Prior art keywords
oligopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006009296T
Other languages
German (de)
English (en)
Inventor
Veronique Gillon
Philippe Moussou
Jean-Luc Contet-Audonneau
Olga Freis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis IP Management GmbH
Original Assignee
Cognis IP Management GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis IP Management GmbH filed Critical Cognis IP Management GmbH
Publication of DE602006009296D1 publication Critical patent/DE602006009296D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
DE602006009296T 2005-11-03 2006-10-25 Oligopeptide und ihre verwendung Active DE602006009296D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05023954A EP1782819A1 (en) 2005-11-03 2005-11-03 Oligopeptides and their use
PCT/EP2006/010258 WO2007051550A1 (en) 2005-11-03 2006-10-25 Oligopeptides and their use

Publications (1)

Publication Number Publication Date
DE602006009296D1 true DE602006009296D1 (de) 2009-10-29

Family

ID=36371046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006009296T Active DE602006009296D1 (de) 2005-11-03 2006-10-25 Oligopeptide und ihre verwendung

Country Status (7)

Country Link
US (2) US8101574B2 (https=)
EP (2) EP1782819A1 (https=)
JP (2) JP5770965B2 (https=)
KR (1) KR101421742B1 (https=)
DE (1) DE602006009296D1 (https=)
ES (1) ES2332740T3 (https=)
WO (1) WO2007051550A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
DE102009002285A1 (de) * 2009-04-08 2010-10-14 Henkel Ag & Co. Kgaa Kopfhautschonende Shampoos und Conditioner
IT1407715B1 (it) * 2010-06-18 2014-04-30 Alphrema Srl Composizioni ad uso topico per la profilassi ed il trattamento igienico di alcune problematiche di patologia ano-rettale, come emorroidi, ragadi, ascessi e fistole.
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
FR3012811B1 (fr) * 2013-11-05 2015-12-25 Basf Beauty Care Solutions France Sas Oligopeptides et leurs utilisations
ITBS20130177A1 (it) * 2013-11-27 2015-05-28 Gianpaolo Pizzoli Preparazione cosmetica
US20170281509A1 (en) * 2014-09-12 2017-10-05 Gojo Industries, Inc. Compositions and methods for mitigating skin irritation
KR101851236B1 (ko) 2015-07-06 2018-04-24 김철군 동충하초 재배용 배지조성물 및 동충하초 재배방법
US20190248834A1 (en) * 2016-06-27 2019-08-15 Ruey J. Yu Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof
KR20190065916A (ko) 2017-12-04 2019-06-12 김철군 동충하초 재배용 배지조성물 및 동충하초의 재배방법
CN119143848B (zh) * 2023-12-26 2025-11-25 杭州湃肽生化科技有限公司 环七肽-4及其制备方法及应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU68901A1 (https=) 1973-11-30 1975-08-20
US4172887A (en) * 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
NL8005121A (nl) 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
JPS6299315A (ja) * 1985-10-25 1987-05-08 Kanebo Ltd 皮膚化粧料
US5702688A (en) * 1986-12-23 1997-12-30 Tristrata Technology, Inc. Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
SE9503924D0 (sv) 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
IS4261A (is) 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
JPH0848695A (ja) * 1994-08-05 1996-02-20 Meito Sangyo Kk ポルフイロモナス・ジンジバリスのタイプｉｉ線毛蛋白質の配列を含有するペプチド類及びその用途
JPH08337537A (ja) * 1995-06-15 1996-12-24 Kao Corp 細胞間接着阻害ペプチド
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
JPH10330398A (ja) * 1997-05-28 1998-12-15 Asahi Glass Co Ltd 新規環状ペプチド
DE19756377A1 (de) 1997-12-18 1999-06-24 Beiersdorf Ag Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
PL189753B1 (pl) * 1998-11-12 2005-09-30 Victor Hruby Nowe pochodne peptydowe o aktywności przeciwbólowej oraz sposób ich otrzymywania
US6048902A (en) * 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
IL153359A0 (en) * 2000-06-16 2003-07-06 Hercules Inc Peptides, compositions and methods for the treatment of burkholderia cepacia
WO2002010195A2 (en) * 2000-08-02 2002-02-07 Theratechnologies Inc. Modified peptides with increased potency
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
EP1427438A2 (en) 2001-09-03 2004-06-16 The University of Bristol Inflammation modulatory compound comprising an endomorphin
JP2004175687A (ja) 2002-11-25 2004-06-24 Shiseido Co Ltd 皮膚バリアー機能回復促進剤
FR2857588B1 (fr) * 2003-07-17 2007-11-30 Oreal Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie
EP1982997B1 (en) * 2004-09-01 2012-08-08 Allergan, Inc. Degradable clostridial toxins
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
WO2008056207A1 (en) * 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
DE102009002286A1 (de) * 2009-04-08 2010-02-11 Henkel Ag & Co. Kgaa Haarfärbe/wellmittel mit verbesserter Hautverträglichkeit
EP2427475B1 (en) * 2009-05-08 2020-11-04 Techfields Biochem Co., Ltd. High penetration prodrug compositions of peptides and peptide-related compounds
WO2011146922A2 (en) * 2010-05-21 2011-11-24 Cytogel Pharma, Llc Materials and methods for treatment of inflammation

Also Published As

Publication number Publication date
US20120129784A1 (en) 2012-05-24
KR101421742B1 (ko) 2014-07-30
JP5837539B2 (ja) 2015-12-24
US8101574B2 (en) 2012-01-24
US8399415B2 (en) 2013-03-19
JP2009514906A (ja) 2009-04-09
JP2013241433A (ja) 2013-12-05
ES2332740T3 (es) 2010-02-11
EP1782819A1 (en) 2007-05-09
EP1951276B1 (en) 2009-09-16
WO2007051550A1 (en) 2007-05-10
EP1951276A1 (en) 2008-08-06
JP5770965B2 (ja) 2015-08-26
US20090075906A1 (en) 2009-03-19
KR20080067343A (ko) 2008-07-18

Similar Documents

Publication Publication Date Title
ATE520681T1 (de) N-thioanthranilamidverbindungen und ihre verwendung als pestizide
ATE543808T1 (de) 5,6-ring-annelierte indolderivate und ihre verwendung
EP1746902A4 (en) MULTI-LECTIN AFFINITY CHROMATOGRAPHY AND USES THEREOF
ATE531712T1 (de) Substituierte aryloxazole und ihre verwendung
DE502005007106D1 (de) Substituierte phenylaminothiazole und ihre verwendung
DE602005014815D1 (de) Flüssigwaschmittel und ihre verwendung
ATE440093T1 (de) 1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide
ATE547002T1 (de) Pestizide und ihre verwendung
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
ATE430133T1 (de) N-hydroxyamid derivate und ihre verwendung
DE602005021959D1 (de) Substituierte diazaspiroä4.5üdecanderivate und der
DE602006016189D1 (de) Pigmentdispergatoren und ihre Verwendung
ATE493396T1 (de) Neue indazolcarboxamide und ihre verwendung
DE602006009296D1 (de) Oligopeptide und ihre verwendung
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DE502005002170D1 (de) Amphiphile polymerzusammensetzungen und ihre verwendung
ATE531259T1 (de) 2-alkyl-cycloalk(en)yl-carboxamide und ihre verwendung als fungizide
ATE475314T1 (de) Esterverbindung und ihre verwendung
EP1812055A4 (en) ANTIGENS OF CHLAMYDIA AND APPLICATIONS OF SAID ANTIGENS
DE602007006314D1 (de) Anzeigevorrichtung und ihre verwendung
DE502006007801D1 (de) Antennenanordnung sowie verwendung
ATE411817T1 (de) Benzothiazolformulierungen und ihre verwendung
SE0600005L (sv) Värmare
DE602006007777D1 (de) Reductase Gen und dessen Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition